AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 81 min read$USNA

Jones Paul A. sold $103K of USNA

Jones Paul A. (CHIEF PEOPLE OFFICER) sold 5,561 shares of USANA HEALTH SCIENCES INC (USNA) at $18.50 ($0.10M total) on 2026-06-08.

Original reporting
SEC EDGAR · Jones Paul A.
Published Jun 8, 2026, 10:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 8, 2026, 10:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$USNA
Neutral
medium confidence
Mentioned
$USNA
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$USNANeutralLow
01

Why it matters

Discloses an officer’s open-market sale of USNA shares; typically more relevant for sentiment than for forecasting earnings or corporate actions.

02

Market read

A fresh insider-sale datapoint for USNA, but no fundamental catalyst is provided in the text.

03

What to watch

The filing shows the post-transaction holdings are 0 shares, but without context on compensation, prior grants, or broader insider activity, the signal is limited.

Relevance 4/10Novelty 6/10Timing: today (2026-06-08) SEC Form 4 disclosure

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for USANA Health Sciences.

Company-level read

Ticker impact

$USNANeutralMedium confidence
Context

USANA Health Sciences insider Form 4 shows Chief People Officer Paul A. Jones sold 5,561 shares in an open-market transaction on 2026-06-08.

Expected impact

Likely minimal near-term impact; any effect is more sentiment/positioning than fundamentals.

Evidence & confidence

The filing is a direct insider sale (not a buy), but the article provides no accompanying company-specific catalyst (earnings, guidance, deal, enforcement) beyond the transaction details.

Market effects

Sector

No sector-level read-across; this is a single-company insider transaction.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Insider sales can be planned for diversification or tax needs; the absence of a 10b5-1 plan detail doesn’t prove negative fundamentals by itself.

Key entities

  • issuer
    USANA Health Sciences Inc

    Company whose shares were sold by an insider in the reported Form 4 transaction.

  • insider
    Paul A. Jones

    Chief People Officer who sold 5,561 USNA shares on 2026-06-08.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

USNA insider trading history →

Related articles

AUG 12
$USNAMedAI 8/10

USANA (USNA) Q2 2026 Earnings Call Transcript

USANA (USNA) held its Q2 2026 earnings call. Management said Core Nutritional was stable, with Mainland China showing renewed strength. The company recorded a preliminary $29 million noncash goodwill impairment and $9 million income tax expense on a $19 million pretax loss. USANA ended the quarter with $169 million cash, zero debt, and $20 million free cash flow, and lowered its fiscal 2026 outlook due to HYA DTC marketing and Rise net sales.

yahoo.com6 min
AUG 11
$USNAMedAI 8/10

USANA Health Sciences Q2 Earnings Call Highlights

USANA Health Sciences (NYSE:USNA) reported Q2 updates including a $29 million preliminary non-cash goodwill impairment tied to its Hiya reporting unit and $9 million income tax expense on a $19 million pre-tax loss. Management cited about $30 million to $40 million top-line pressure and $4 million to $5 million margin pressure, plus a Rise packaging disruption. USANA ended with $169 million cash and no debt.

yahoo.com6 min
AUG 9
$USNAHighAI 9/10

Why Usana Health Sciences Stock Plummeted This Week

Usana Health Sciences (USNA) shares fell about 30% after its Aug. 4 Q2 results missed expectations and guidance disappointed. The company reported non-GAAP EPS of $0.07 on about $223M sales, with sales and profit below analyst averages. It also took a $29M goodwill impairment on Hiya, cut 2024 guidance to an $11M loss and lowered sales to $910M from $925M-$1B.

yahoo.com6 min
AUG 4
$USNAHigh

USANA HEALTH SCIENCES INC (USNA): Results of Operations and Financial Condition

USANA HEALTH SCIENCES INC (USNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. USANA Health Sciences Reports Second Quarter 2026 Results Company Continues Evolution to a Diversified, Omnichannel Health and Wellness Business SALT LAKE CITY, August 4, 2026 (BUSINESS WIRE)—USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fisca

SEC EDGAR 8-K6 min